Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five brokerages that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $243.3333.
Several research firms recently issued reports on NUTX. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Zacks Research raised shares of Nutex Health to a “hold” rating in a research report on Monday. Lake Street Capital initiated coverage on shares of Nutex Health in a research report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price target for the company. B. Riley Financial initiated coverage on shares of Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 price target for the company. Finally, Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th.
Check Out Our Latest Report on Nutex Health
Institutional Investors Weigh In On Nutex Health
Nutex Health Trading Up 2.0%
Shares of Nutex Health stock opened at $170.89 on Wednesday. Nutex Health has a 52-week low of $77.21 and a 52-week high of $193.07. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The company’s 50-day simple moving average is $131.86 and its 200-day simple moving average is $129.94. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 13.21 and a beta of 0.26.
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The firm had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. As a group, equities research analysts anticipate that Nutex Health will post 22.72 earnings per share for the current year.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Further Reading
- Five stocks we like better than Nutex Health
- 3 Charts That Could Change the Course of Summer Trading
- Burger King’s Turnaround Is Putting Restaurant Brands Back in Focus
- Short Squeeze Alert—Moderna Stock Surges on New Strategy
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
